These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27870908)

  • 21. Which Biomarker is the Best for Predicting Mortality in Incident Peritoneal Dialysis Patients: NT-ProBNP, Cardiac TnT, or hsCRP?: A Prospective Observational Study.
    Oh HJ; Lee MJ; Kwon YE; Park KS; Park JT; Han SH; Yoo TH; Kim YL; Kim YS; Yang CW; Kim NH; Kang SW
    Medicine (Baltimore); 2015 Nov; 94(44):e1636. PubMed ID: 26554763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
    Das SR; Drazner MH; Dries DL; Vega GL; Stanek HG; Abdullah SM; Canham RM; Chung AK; Leonard D; Wians FH; de Lemos JA
    Circulation; 2005 Oct; 112(14):2163-8. PubMed ID: 16203929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NT-proBNP and troponin T levels differ after haemodialysis with a low versus high flux membrane.
    Laveborn E; Lindmark K; Skagerlind M; Stegmayr B
    Int J Artif Organs; 2015 Feb; 38(2):69-75. PubMed ID: 25744196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.
    Huang FY; Wang H; Huang BT; Liu W; Peng Y; Zhang C; Xia TL; Wang PJ; Zuo ZL; Heng Y; Liu RS; Pu XB; Gui YY; Chen SJ; Zhu Y; Chen M
    Cardiovasc Diabetol; 2016 Apr; 15():58. PubMed ID: 27048159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.
    Gutiérrez OM; Tamez H; Bhan I; Zazra J; Tonelli M; Wolf M; Januzzi JL; Chang Y; Thadhani R
    Clin Chem; 2008 Aug; 54(8):1339-48. PubMed ID: 18539645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoterminal B-type natriuretic peptide (NT-proBNP) in end-stage renal failure patients on regular hemodialysis: does it have diagnostic and prognostic implications?
    Pimenta J; Sampaio F; Martins P; Carvalho B; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Nephron Clin Pract; 2009; 111(3):c182-8. PubMed ID: 19194108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.
    Snaedal S; Qureshi AR; Carrero JJ; Heimbürger O; Stenvinkel P; Bárány P
    Blood Purif; 2014; 37(2):138-45. PubMed ID: 24732340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between fluid status as assessed by bioimpedance analysis and NT-pro BNP, blood pressure and left ventricular mass index in hemodialysis patients.
    Yilmaz Z; Yildirim Y; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME; Ulgen MS; Yildiz A
    Clin Ter; 2014; 165(1):e52-8. PubMed ID: 24589961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Old markers, new approach to assessment of risk in heart failure.
    Kodziszewska K; Leszek P; Korewicki J; Piotrowski W
    Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.